This paper is in the following e-collection/theme issue:

Formative Evaluation of Digital Health Interventions (2211) Web-based and Mobile Health Interventions (3119) Insomnia and Sleep Hygiene (151)

Published on in Vol 3, No 2 (2019): Apr-Jun

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/12635, first published .
Treatment Preferences for Internet-Based Cognitive Behavioral Therapy for Insomnia in Japan: Online Survey

Treatment Preferences for Internet-Based Cognitive Behavioral Therapy for Insomnia in Japan: Online Survey

Treatment Preferences for Internet-Based Cognitive Behavioral Therapy for Insomnia in Japan: Online Survey

Authors of this article:

Daisuke Sato1, 2 Author Orcid Image ;   Chihiro Sutoh1 Author Orcid Image ;   Yoichi Seki3 Author Orcid Image ;   Eiichi Nagai4 Author Orcid Image ;   Eiji Shimizu1, 3, 5 Author Orcid Image
Article Authors Cited by (5) Tweetations Metrics

    Original Paper

    1Department of Cognitive Behavioral Physiology, Graduate School of Medicine, Chiba University, Chiba, Japan

    2Department of Rehabilitation Sciences, Chiba Prefectural University of Health Sciences, Chiba, Japan

    3Cognitive Behavioral Therapy Center, Chiba University Hospital, Chiba, Japan

    4Clinical Research Center, Chiba University Hospital, Chiba, Japan

    5Research Center for Child Mental Development, Chiba University, Chiba, Japan

    Corresponding Author:

    Daisuke Sato, PhD

    Department of Cognitive Behavioral Physiology

    Graduate School of Medicine

    Chiba University

    1-8-1, Inohana, Chuo-ku, Chiba-shi

    Chiba, 260-8670

    Japan

    Phone: 81 43 226 2027

    Email: daisuke-sato@umin.ac.jp


    Background: The internet has the potential to increase individuals’ access to cognitive behavioral therapy (CBT) for insomnia at low cost. However, treatment preferences regarding internet-based computerized CBT for insomnia have not been fully examined.

    Objective: The aim was to conduct an anonymous online survey to evaluate treatment preferences for insomnia among patients with insomnia and individuals without insomnia.

    Methods: We developed an online survey to recruit a total of 600 participants living in the Kanto district in Japan. There were three subgroups: 200 medicated individuals with insomnia, 200 unmedicated individuals with insomnia, and 200 individuals without insomnia. The survey asked questions about the severity of the respondent’s insomnia (using the Athens Insomnia Scale), the frequency of sleep medication use and the level of satisfaction with sleep medication use, the respondent’s knowledge of CBT, his or her preference for CBT for insomnia before drug therapy, preference for CBT versus drug therapy, and preference for internet-based CBT versus face-to-face CBT.

    Results: Of the 600 respondents, 47.7% (286/600) indicated that they received CBT before drug therapy, and 57.2% (343/600) preferred CBT for insomnia to drug therapy. In addition, 47.0% (282/600) preferred internet-based CBT for insomnia to face-to-face CBT. Although the respondents with insomnia who were taking an insomnia medication had a relatively lower preference for internet-based CBT (40.5%, 81/200), the respondents with insomnia who were not taking an insomnia medication had a relatively higher preference for internet-based CBT (55.5%, 111/200).

    Conclusions: The results of our online survey suggest that approximately half of the people queried preferred CBT for insomnia to drug therapy, and half of the respondents preferred internet-based CBT for insomnia to face-to-face CBT.

    JMIR Form Res 2019;3(2):e12635

    doi:10.2196/12635

    Keywords

    patient preference; insomnia; internet-based cognitive behavioral therapy 


    According to the Diagnostic and Statistical Manual of Mental Disorders (Fifth Edition), insomnia is a sleep disorder characterized by recurrent poor sleep quality or quantity that causes distress or impairment in important areas of functioning. Epidemiological studies suggest that the prevalence of clinical insomnia disorder ranges from 10% to 12% [1, 2], and the problems are often long-lasting [1]. There are two treatment options for individuals who have insomnia: cognitive behavioral therapy (CBT) [2-4] and pharmacotherapy, including nonbenzodiazepines, benzodiazepines, melatonin agonists, and an orexin receptor antagonist. In their systematic review, Mitchell et al [5] stated that over the long term the effectiveness of CBT for insomnia is superior to the effectiveness of benzodiazepine and non-benzodiazepine drugs. It is worthwhile to note that benzodiazepines are more frequently prescribed in Japan than in any other country [6].

    Although there is evidence that pharmacological treatments improve insomnia (especially in the short term), these treatments have some significant potential adverse effects, including residual sedation and memory impairment. Patients with insomnia often report a preference for CBT. For example, Vincent and Lionberg [7] reported that at pretreatment in an outpatient hospital setting in Canada, CBT was significantly preferred over pharmacological therapy by 43 participants based on overall acceptability ratings. In a study from Australia, Walters et al [8] showed that a series of individuals with schizophrenia or schizoaffective disorders preferred CBT when given the choice of pharmacotherapy, melatonin, and CBT.

    A problem related to CBT is that access to face-to-face CBT is extremely limited in some regions, including Japan, due to human resource and expertise constraints [9-12]. Accumulating evidence in recent years suggests that internet-based, computerized CBT for insomnia can be an effective treatment [13-15], and attention has turned to internet-based CBT for insomnia as an alternative to face-to-face CBT [16]. Web programs are accessible independent of the user’s location and can be conducted on one’s own time and at a low cost. Although the potential preference for CBT for insomnia over pharmacotherapy has been investigated in Western countries, there have been no studies of treatment preferences among individuals with and without insomnia in Japan [17,18]. In this study, we conducted an anonymous online survey to evaluate treatment preferences for insomnia among medicated individuals with insomnia, nonmedicated individuals with insomnia, and individuals without insomnia.


    Survey Respondents

    We had an online research agency (Cross Marketing Inc, Tokyo) oversee our Web-based survey. After being provided a thorough understanding of our research and agreeing to voluntarily participate in the study, 600 participants were recruited from the Kanto district in Japan through the online research provider. They consisted of 200 individuals with insomnia who were using a medication for insomnia, 200 individuals with insomnia who were not taking any insomnia medication, and 200 individuals without insomnia by their self-reports. Each group of 200 participants consisted of 100 men, including 20 men each in their twenties, thirties, forties, fifties, and sixties, and 100 women, including 20 women each in their twenties, thirties, forties, fifties, and sixties, to match the groups by age and gender.

    Procedure

    The candidate respondent received brief text-based information about the survey, including its objectives and conditions for participation (informed consent). The survey consisted of two parts. The first part asked demographic questions including gender, age, living area, employment status, and presence and severity of insomnia using the Athens Insomnia Scale (AIS), a self-reported psychometric questionnaire consisting of eight items developed by Soldatos et al [19].

    The survey’s second part consisted of the following questions about treatment for insomnia.

    Frequency of sleep medication use and the level of satisfaction with sleep medication use:

    1. How often do you take medication for insomnia?
    2. Are you satisfied with your current insomnia medication?

    Knowledge of CBT:

    1. Have you heard of cognitive behavioral therapy (CBT)? Did you know that CBT is also a treatment for mental disorders such as depressive disorders and anxiety disorders?
    2. As a treatment for insomnia, it has been shown that cognitive behavioral therapy (CBT) is medically effective. Did you know that CBT is effective for insomnia?

    Preference for CBT before drug therapy, preference for CBT versus drug therapy, and preference for internet-based CBT versus face-to-face CBT:

    1. Let’s assume that you received your diagnosis of insomnia from your doctor. Imagine that you were advised to take cognitive behavioral therapy (CBT) before drug therapy. In such a case, have you received CBT?
    2. If you had to choose either CBT for insomnia or drug therapy for insomnia, which would you choose?
    3. Aside from the method of CBT for insomnia in face-to-face sessions with a therapist, if there is a way to receive CBT for insomnia via a computer program on the internet and support from a therapist by email, which would you choose?

    Statistical Analysis

    We used descriptive analyses (numbers, frequencies, percentages, means and standard deviations). We compared differences in each survey item among the three respondent groups, using the chi-square test, ANOVA, and a residual analysis [20]. An alpha level of .05 was used. All data were analyzed using SPSS for Windows version 21 (SPSS, Chicago, IL, USA).

    Ethical Approval

    The study was approved by the Regional Ethical Review Board, Faculty of Medicine, Chiba University (2017-5-19; No. 2711).


    Demographic Characteristics of the Survey Respondents

    As designed, a total of 600 respondents (300 men and 300 women; mean age 45, SD 14 years, range 20-69 years) completed the online survey (Table 1). As shown by the respondents’ use of the AIS, the respondents with insomnia who were taking an insomnia medication and respondents with insomnia who were not taking an insomnia medication had significantly more severe insomnia compared to the respondents without insomnia. When we defined an AIS total score of 6 or higher as insomnia, 90.0% (180/200) of the respondents with insomnia were using an insomnia medication and 94.5% (189/200) of the respondents with insomnia were not taking an insomnia medication compared to 52.0% (104/200) of the respondents without insomnia (see Table 1). There were also significant differences among the three respondent groups in employment status and AIS score (see Table 1).

    Table 1. The demographic characteristics of the 600 survey respondents.
    VariableWith insomnia, using medication (n=200)With insomnia, not using medication (n=200)Without insomnia (n=200)χ2 (df)F value (df1,df2)P value
    Sex, n (%)


    		0.0 (2)
    		>.99

    		Women100 (50.0)100 (50.0)100 (50.0)



    		Men100 (50.0)100 (50.0)100 (50.0)


    Age (years), mean (SD)45 (14)45 (14)45 (14)
    		0.01 (2,398)>.99
    Employment status


    		0.0 (10)
    		<.001

    		Full-time66 (25.9)98 (38.4)91 (35.7)



    		Part-time34 (41.0)19 (22.9)30 (36.1)



    		Self-employed11 (55.0)2 (10.0)7 (35.0)



    		Housewife25 (28.7)36 (41.4)26 (29.9)



    		Unemployed43 (45.3)30 (31.6)22 (23.2)



    		Other21 (35.0)15 (25.0)24 (40.0)


    AISa score, mean (SD)10.31 (4.46)10.28 (3.60)5.96 (3.14)
    		87.97 (2,597)<.001
    Insomnia (AIS ≥6)180 (38.1)189 (40.0)104 (22.0)130.7 (2)
    		<.001

    aAIS: Athens Insomnia Scale.

    Level of Satisfaction With Sleep Medication Use

    The respondents with insomnia who were taking an insomnia medication (n=200) were asked about the frequency of their insomnia medication use; 68.0% (136/200) reported that they used an insomnia medication every night, and 95.5% (191/200) reported using such a medication at least once per week (Table 2). The respondents who indicated that they used an insomnia medication were also asked about their level of satisfaction with the sleep medication use: 54.0% (108/200) were satisfied, 27.5% (55/200) were neutral, and 18.5% (37/200) were dissatisfied.

    Table 2. Frequency of sleep medication use and level of satisfaction with sleep medication use among the 200 respondents with insomnia who were using an insomnia medication.
    Questions and answersRespondents, n (%)
    How often do you take medicine?

    		Every night (time per day)136 (68.0)

    		3-4 times per week40 (20.0)

    		1 time per week15 (7.5)

    		1 time per 2 weeks4 (2.0)

    		1 time per month1 (0.5)

    		<1 time per 2 months4 (2.0)
    Are you satisfied with your current medicine?

    		Very satisfied35 (17.5)

    		Satisfied73 (36.5)

    		Neutral55 (27.5)

    		Dissatisfied28 (14.0)

    		Very dissatisfied9 (4.5)

    Knowledge of Cognitive Behavioral Therapy

    All respondents were asked about their knowledge of CBT. There were significant differences among the three respondent groups in their knowledge of CBT and the effects of CBT (Table 3): 55.0% (330/600) of the respondents had no knowledge of CBT. Among the three groups, the percentage of those who had no knowledge of CBT were as follows: 39.0% (78/200) of the respondents with insomnia who were taking an insomnia medication, 54.0% (108/200) of the respondents with insomnia who were not taking an insomnia medication, and 72.0% (144/200) of the respondents without insomnia. In the group of respondents with insomnia who were using medication, the response “I have heard of CBT, and I know that it is an insomnia treatment” was significantly more frequent comparing the three respondent groups’ answers. Conversely, the response “I have never heard of CBT, and I did not know that it is an insomnia treatment” was significantly less comparing the three respondent groups’ answers. Among the group of respondents with insomnia who were not taking insomnia medication, the response “I have heard of CBT, and I know that it is an insomnia treatment” was significantly less frequent comparing the three respondent groups’ answers, and “I have heard of CBT, and I did not know that it is an insomnia treatment” was significantly more frequent comparing the three respondent groups’ answers. In the group without insomnia, the response “I have heard of CBT, and I know that it is an insomnia treatment” was significantly more frequent, and the response “I have never heard of CBT, and I did not know that it is an insomnia treatment” was significantly less frequent comparing the three respondent groups’ answers (Table 4).

    Even among the respondents who had heard of CBT (n=270), 68.5% did not know that CBT is effective for insomnia. Among the respondents with insomnia who were using an insomnia medication, the response “Do you know that CBT is effective for insomnia? Yes, I know” was significantly more frequent comparing the three respondent groups’ answers, and “No, I do not know” was significantly less frequent comparing the three respondent groups’ answers. Among the survey respondents with insomnia who were not using an insomnia medication, the response “Do you know that CBT is effective for insomnia? Yes, I know” was significantly less frequent comparing the three respondent groups’ answers, and “No, I do not know” was significantly more frequent comparing the three respondent groups’ answers (Table 3).

    Table 3. Knowledge of cognitive behavioral therapy (CBT) in general.
    Question and answersWith insomnia, using medication (n=200)With insomnia, not using medication (n=200)Without insomnia (n=200)Total (N=600)

    		n (%)Adjusted residualn (%)Adjusted residualn (%)Adjusted residualn (%)P valuea
    Have you heard of cognitive behavioral therapy (CBT)? Did you know that it is a treatment for mental disorders such as depression disorders and anxiety disorders?

    		I have heard of CBT, and I know that it is an insomnia treatment82 (41.0)7.9b,c32 (16.0)−2.5b,d18 (9.0)−5.4b,c132 (22.0)<.001

    		I have heard of CBT, but I did not know that it is an insomnia treatment40 (20.0)−1.260 (30.0)2.9b,c38 (19.0)−1.6138 (23.0)

    		I have never heard of CBT, and I did not know that it is an insomnia treatment78 (39.0)−5.6b,c108 (54.0)−0.3144 (72.0)5.9b,c330 (55.0)

    aFrom Pearson chi-square values.

    bCells with significant adjusted standardized residuals.

    cThe adjusted standardized residual is 2.58 or greater (or, alternatively, less than −2.58), its associated probability is less than 0.01.

    dThe adjusted standardized residual is 1.96 or greater (or, alternatively, less than −1.96), its associated probability is less than 0.05.

    Table 4. Knowledge of cognitive behavioral therapy (CBT) for insomnia.
    Question and answersWith insomnia, using medication (n=122)With insomnia, not using medication (n=92)Without insomnia (n=56)Total (N=270)

    		n (%)Adjusted residualn (%)Adjusted residualn (%)Adjusted residualn (%)P valuea
    As a treatment for insomnia, it has been shown that CBT is medically effective. Did you know that CBT is effective for insomnia?

    		Total122 (100.0)
    		92 (100.0)
    		56 (100.0)
    		270 (100.0)<.001

    		Yes, I know54 (44.3)4.1b,c18 (19.6)−3.0b,c13 (31.5)−1.585 (31.5)

    		No, I did not know68 (55.7)−4.1b,c74 (80.4)3.0b,c43 (68.5)1.5185 (68.5)

    aFrom Pearson chi-square values.

    bCells with significant adjusted standardized residuals.

    cThe adjusted standardized residual is 2.58 or greater (or, alternatively, less than −2.58), its associated probability is less than 0.01.

    Preference for Internet-Based Cognitive Behavioral Therapy for Insomnia

    All respondents were asked whether they had undergone CBT before drug therapy, and 47.7% (286/600) responded they had undergone CBT. There were no significant differences in the rate among the three groups: with insomnia using medication (51.5%,103/200), with insomnia not using medication (47.5%, 95/200), and without insomnia (44.0%, 88/200) (Table 5).

    Notably, 57.2% (343/600) of the total respondents preferred CBT over drug therapy for insomnia. Among those with insomnia who were using an insomnia medication, the statement “I choose CBT” was significantly less frequent comparing the three respondent groups’ answers, and “I choose drug therapy” was significantly more frequent comparing the three respondent groups’ answers. In both groups of respondents with insomnia who were not taking an insomnia medication and the respondents without insomnia, the statement “I choose CBT” was significantly more frequent comparing the three respondent groups’ answers, and “I choose drug therapy” was significantly less frequent comparing the three respondent groups’ answers (Table 5). Although respondents with insomnia who were using insomnia medications had a relatively lower preference for CBT (40.5%, 81/200), both those with insomnia who were not taking an insomnia medication and the respondents without insomnia had a relatively higher preference for CBT (64.0%, 128/200 and 67.0%, 134/200, respectively).

    Table 5. Preference for cognitive behavioral therapy (CBT) before drug therapy versus drug therapy, and preference for internet-based CBT versus face-to-face CBT.
    Questions and answersWith insomnia, using medication (n=200)With insomnia, not using medication (n=200)Without insomnia, (n=200)Total (N=600)

    		n (%)Adjusted residualn (%)Adjusted residualn (%)Adjusted residualn (%)P valuea
    Let’s assume that you received your diagnosis of insomnia from your doctor. Imagine that you were advised to participate in cognitive behavioral therapy (CBT) before drug therapy. In such a case, do you participate in CBT?

    		Yes, I receive CBT103 (51.5)1.395 (47.5)−0.188 (44.0)−1.3286 (47.7).32

    		No. I do not receive CBT97 (48.5)−1.3105 (52.5)0.1112 (56.0)1.3314 (52.3)
    If you had to choose only one of the two as a treatment for insomnia, would you choose CBT or drug therapy?

    		I choose CBT81 (40.5)−5.8b,c128 (64.0)2.4b,d134 (67.0)3.4b,c343 (57.2)<.001

    		I choose drug therapy119 (59.5)5.8b,c72 (36.0)−2.4b, d66 (33.0)−3.4b,c257 (42.8)
    Other than CBT for insomnia in face-to-face sessions with a therapist, if there is a way to receive CBT via the internet and support from a therapist by email, which do you choose?

    		I choose face-to-face CBT119 (59.5)2.3b,d89 (44.5)−2.9b,c110 (53.0)0.7318 (53.0).009

    		I choose CBT on the internet81 (40.5)−2.3b,d111 (55.5)2.9b,c90 (47.0)−0.7282 (47.0)

    aFrom chi-square values.

    bCells with significant adjusted standardized residuals.

    cThe adjusted standardized residual is 2.58 or greater (or, alternatively, less than −2.58), its associated probability is less than 0.01.

    dThe adjusted standardized residual is 1.96 or greater (or, alternatively, less than −1.96), its associated probability is less than 0.05.

    Of the total number of respondents, 47.0% (282/600) preferred internet-based CBT for insomnia to face-to-face CBT. In the group with insomnia taking an insomnia medication, the statement “I choose face-to-face CBT” was chosen significantly more frequently comparing the three respondent groups’ answers, and “I choose computerized CBT on the internet” was chosen less frequently when comparing the three respondent groups’ answers. Among the respondents with insomnia not using insomnia medication, “I choose face-to-face CBT” was chosen significantly less frequently when comparing the three respondent groups’ answers, and “I choose computerized CBT on the internet” was more chosen more frequently when comparing the three respondent groups’ answers (Table 5).

    Although the group with insomnia using an insomnia medication had a relatively lower preference for internet-based CBT (40.5%, 81/200), the group with insomnia not using medication for it had a relatively higher preference for internet-based CBT (55.5%, 111/200).


    Principal Findings

    Our Web-based survey of 600 individuals in Japan revealed that approximately half (57.2%, 343/600) of the respondents preferred CBT for insomnia to drug therapy, and half (47.0%, 282/600) preferred internet CBT for insomnia over face-to-face CBT.

    Culver et al [21] reported that 57.7% of female veterans (N=1538) in the United States rated nonmedication treatment of insomnia as very acceptable, whereas only 33.5% rated medication treatment as very acceptable. Sedov et al [22] reported that 50.9% of a series of pregnant women in Canada (N=187) described CBT as their first choice for the treatment of insomnia, 11.8% selected pharmacotherapy, and 37.3% selected acupuncture if they experienced insomnia. Together, these results suggest a preference for CBT for insomnia over pharmacotherapy [22].

    Regarding internet-based CBT, Cheung et al [23] conducted semistructured interviews in Australia, and they reported that 56.86% of their patients with insomnia (N=51) had a preference for face-to-face CBT, and 43.13% had a preference for internet-based CBT. Their results are similar to ours.

    The treatment plan for an individual with insomnia should be tailored according to his or her values and preferences. Further research is needed to increase the availability of more effective internet CBT in addition to face-to-face CBT and pharmacotherapy.

    Limitations

    Although our online survey obtained valuable information, our study has some limitations including the sampling methods. First, instead of random sampling, we used a stratified sample based on gender and age ranging from people in their twenties to their sixties from an internet inquiry to conduct our online survey. Individuals younger than 20 or older than 70 were excluded. However, all age groups are affected by insomnia, and the incidence tends to increase with age. In a study conducted in the United States, Ancoli-Israel et al [24] reported that 9% of 1000 subjects aged 18 years and older and 20% of 1000 subjects aged 65 years and older had chronic insomnia. Future studies should include people older than 70 years old. Older people have less access to online surveys than the general population. In that case, the use of a face-to-face survey and/or a telephone survey may be necessary to obtain data from people in their seventies. Second, we were unable to elucidate the insomnia severity or age. Third, the number of people using CBT was unclear. The questionnaires should include a number of insomnia patients using CBT with and without medication. Finally, the reason for preference was unclear. The questionnaires should include a reason for choice of medication, face-to-face CBT, and internet-based CBT.

    Conclusions

    The responses to our online survey indicate that approximately half of the respondents preferred CBT over drug therapy for insomnia, and half preferred internet-based CBT for insomnia over face-to-face CBT.

    Conflicts of Interest

    None declared.

    1. Morin CM, Bélanger L, LeBlanc M, Ivers H, Savard J, Espie CA, et al. The natural history of insomnia: a population-based 3-year longitudinal study. Arch Intern Med 2009 Mar 09;169(5):447-453. [CrossRef] [Medline]
    2. Irwin MR, Cole JC, Nicassio PM. Comparative meta-analysis of behavioral interventions for insomnia and their efficacy in middle-aged adults and in older adults 55+ years of age. Health Psychol 2006 Jan;25(1):3-14. [CrossRef] [Medline]
    3. Morin CM, Bootzin RR, Buysse DJ, Edinger JD, Espie CA, Lichstein KL. Psychological and behavioral treatment of insomnia:update of the recent evidence (1998-2004). Sleep 2006 Nov;29(11):1398-1414. [Medline]
    4. Riemann D, Perlis ML. The treatments of chronic insomnia: a review of benzodiazepine receptor agonists and psychological and behavioral therapies. Sleep Med Rev 2009 Jun;13(3):205-214. [CrossRef] [Medline]
    5. Mitchell MD, Gehrman P, Perlis M, Umscheid CA. Comparative effectiveness of cognitive behavioral therapy for insomnia: a systematic review. BMC Fam Pract 2012;13:40 [FREE Full text] [CrossRef] [Medline]
    6. Nakao M, Takeuchi T, Yano E. Prescription of benzodiazepines and antidepressants to outpatients attending a Japanese university hospital. Int J Clin Pharmacol Ther 2007 Jan;45(1):30-35. [Medline]
    7. Vincent N, Lionberg C. Treatment preference and patient satisfaction in chronic insomnia. Sleep 2001 Jun 15;24(4):411-417. [Medline]
    8. Waters F, Chiu VW, Janca A, Atkinson A, Ree M. Preferences for different insomnia treatment options in people with schizophrenia and related psychoses: a qualitative study. Front Psychol 2015 Jul;6:990 [FREE Full text] [CrossRef] [Medline]
    9. Dyas JV, Apekey TA, Tilling M, Ørner R, Middleton H, Siriwardena AN. Patients' and clinicians' experiences of consultations in primary care for sleep problems and insomnia: a focus group study. Br J Gen Pract 2010 May;60(574):e180-e200 [FREE Full text] [CrossRef] [Medline]
    10. Falloon K, Arroll B, Elley C, Fernando A. The assessment and management of insomnia in primary care. BMJ 2011 May 27;342:d2899. [CrossRef] [Medline]
    11. Espie CA. "Stepped care": a health technology solution for delivering cognitive behavioral therapy as a first line insomnia treatment. Sleep 2009 Dec;32(12):1549-1558 [FREE Full text] [Medline]
    12. Espie C, Hames P, McKinstry B. Use of the internet and mobile media for delivery of cognitive behavioral insomnia therapy. Sleep Med Clin 2013;8(3):407-419 [FREE Full text]
    13. Ritterband LM, Thorndike FP, Gonder-Frederick LA, Magee JC, Bailey ET, Saylor DK, et al. Efficacy of an Internet-based behavioral intervention for adults with insomnia. Arch Gen Psychiatry 2009 Jul;66(7):692-698 [FREE Full text] [CrossRef] [Medline]
    14. Vincent N, Lewycky S. Logging on for better sleep: RCT of the effectiveness of online treatment for insomnia. Sleep 2009 Jun;32(6):807-815 [FREE Full text] [Medline]
    15. Espie CA, Kyle SD, Williams C, Ong JC, Douglas NJ, Hames P, et al. A randomized, placebo-controlled trial of online cognitive behavioral therapy for chronic insomnia disorder delivered via an automated media-rich web application. Sleep 2012 Jun;35(6):769-781 [FREE Full text] [CrossRef] [Medline]
    16. Ritterband LM, Thorndike FP. The further rise of internet interventions. Sleep 2012 Jun 01;35(6):737-738 [FREE Full text] [CrossRef] [Medline]
    17. Schutte-Rodin S, Broch L, Buysse D, Dorsey C, Sateia M. Clinical guideline for the evaluation and management of chronic insomnia in adults. J Clin Sleep Med 2008 Oct 15;4(5):487-504 [FREE Full text] [Medline]
    18. Wilson SJ, Nutt DJ, Alford C, Argyropoulos SV, Baldwin DS, Bateson AN, et al. British Association for Psychopharmacology consensus statement on evidence-based treatment of insomnia, parasomnias and circadian rhythm disorders. J Psychopharmacol 2010 Nov;24(11):1577-1601. [CrossRef] [Medline]
    19. Soldatos CR, Dikeos DG, Paparrigopoulos TJ. Athens Insomnia Scale: validation of an instrument based on ICD-10 criteria. J Psychosom Res 2000 Jun;48(6):555-560. [Medline]
    20. Haberman SJ. The analysis of residuals in cross-classified tables. Biometrics 1973 Mar;29(1):205. [CrossRef]
    21. Culver NC, Song Y, Kate McGowan S, Fung CH, Mitchell MN, Rodriguez JC, et al. Acceptability of medication and nonmedication treatment for insomnia among female veterans: effects of age, insomnia severity, and psychiatric symptoms. Clin Ther 2016 Nov;38(11):2373-2385 [FREE Full text] [CrossRef] [Medline]
    22. Sedov ID, Goodman SH, Tomfohr-Madsen LM. Insomnia treatment preferences during pregnancy. J Obstet Gynecol Neonatal Nurs 2017;46(3):e95-e104. [CrossRef] [Medline]
    23. Cheung JM, Bartlett DJ, Armour CL, Laba T, Saini B. Patient perceptions of treatment delivery platforms for cognitive behavioral therapy for insomnia. Behav Sleep Med 2017 Mar 21:1-19. [CrossRef] [Medline]
    24. Ancoli-Israel S, Roth T. Characteristics of insomnia in the United States: results of the 1991 National Sleep Foundation Survey. I. Sleep 1999 May 1;22 Suppl 2:S347-S353. [Medline]

    ‎
    CBT: cognitive behavioral therapy

    Edited by G Eysenbach; submitted 04.11.18; peer-reviewed by A Sano, L Ranandeh; comments to author 05.01.19; revised version received 12.03.19; accepted 30.03.19; published 15.05.19

    Copyright

    ©Daisuke Sato, Chihiro Sutoh, Yoichi Seki, Eiichi Nagai, Eiji Shimizu. Originally published in JMIR Formative Research (http://formative.jmir.org), 15.05.2019.

    This is an open-access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work, first published in JMIR Formative Research, is properly cited. The complete bibliographic information, a link to the original publication on http://formative.jmir.org, as well as this copyright and license information must be included.